Brief: Annexin Q2 Loss Narrows To SEK 8.5 Mln
July 17 (Reuters) - Annexin Pharmaceuticals AB (publ) ANNX.ST: Q2 PROFIT FOR THE PERIOD AMOUNTED TO SEK -8,503 THOUSAND (-14,514) Q2 OPERATING PROFIT SEK -8,583 THOUSAND Source text: ID:nMFN8ylfT8 Further company coverage: ANNX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed